Replimune
REPL
#5612
Rank
NZ$2.51 B
Marketcap
NZ$26.74
Share price
0.51%
Change (1 day)
175.88%
Change (1 year)

Market capitalization of Replimune (REPL)

Market cap: NZ$2.51 Billion

As of August 2026 Replimune has a market cap of NZ$2.51 Billion. This makes Replimune the world's 5612th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Replimune from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.51 B86.73%
2025NZ$1.34 B-19.36%
2024NZ$1.67 B112.5%
2023NZ$0.78 B-63.05%
2022NZ$2.13 B14.53%
2021NZ$1.86 B-23.44%
2020NZ$2.43 B211.23%
2019NZ$0.78 B65.53%
2018NZ$0.47 B

End of Day market cap according to different sources

On Aug 26th, 2026 the market cap of Replimune was reported to be:

NZ$2.51 Billion
by Nasdaq info icon info icon
NZ$2.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.42 B-3.64%๐Ÿ‡บ๐Ÿ‡ธ USA